The Journal follows the Uniform Requirements standards
Manuscripts Submitted to Biomedical for Journals
In the magazine
About the journal
Editing and Web Development
Sponsor
You are in > Home / Posting Rules
Information for authors
The Journal of Osteoporosis and Mineral Metabolism publishes works in Spanish, which will be translated into English in its electronic format, and is offered freely and through its website. Access is complete all items in both languages, no grace period or seizure without registration. The paper version is published only in Spanish, and distributed by mail to SEIOMM partners and subscribers of the magazine.
The manuscripts will be considered by the Steering Committee of the Journal. All manuscripts will be evaluated by at least two referees, experts in this area, which made its assessment in a blinded fashion.
The Expert Committee is constituted by a group of collaborators specialized in different fields of bone and mineral metabolism that perform the evaluation of manuscripts at the request of the Steering Committee of the Journal. On the website of the Journal and in every issue of the Journal published the list of contributors who form the Committee of Experts. Also in the first issue of each year publish the names of reviewers who have actively collaborated with the magazine in the year ending.
The authors, if they wish, propose at least 3 potential external reviewers, of whom, besides the name, you must include your email address and why they believe they can objectively evaluate the article. They may also indicate those reviewers who do not wish to evaluate the manuscript, must also justify this fact, though its handling is strictly confidential by the team of the Journal.
The views and opinions expressed in articles published in the Journal of Osteoporosis and Mineral Metabolism is the author or authors and not necessarily of the Committee. Both the Steering Committee as SEIOMM disclaim any responsibility. Neither the Management Committee or the SEIOMM guarantee or support any product that is advertised in the magazine, nor guarantee claims made by the manufacturer of that product or service.
The Journal Editorial will acknowledge receipt immediately by e-mail also, and the editorial review process begins, which is usually completed in less than 3 months.
2. 1. Cover letter
All manuscripts should be accompanied necessarily a cover letter indicating: 1) the section of the journal in which you want to publish, 2) a brief explanation of what the original contribution and relevance of work in the field of metabolic bone disease, 3) a statement that the manuscript is original and has not been submitted simultaneously to another journal evaluation, and 4) have been observed these "instructions for authors."
2.2. Manuscripts
The full text of the manuscript, from the title page to references should be included in a file written in Word, in Arial size 12, 1.5 line spacing and justified to the left. Pages should be numbered consecutively in the upper right and you should leave a margin of 3 cm in the 4 edges of the page (which will be A4 size).
Only use common abbreviations in the field of medicine and avoid using abbreviations in the title and abstract work. The first occurrence of an abbreviation should be preceded by the full term to which it relates, except in the case of common measurement units, which are expressed in SI units.
The work shall include the information requested below, ordering sections as follows: title page and authors, summary page and keywords, text (introduction, material and methods, results, discussion and references), tables and figures . If necessary, you may include tables and figures in another attachment, with their respective titles and numbering.
2.3. Sections of the manuscript
2.3.1. Title page and authors:
Shall include the following information:
- The title, which should adequately describe the content of work. It should be brief, clear and informative. Include the full name and surname of the authors, or both names separate or by script, depending on how the authors prefer to appear in publications.
- The name (s) department (s) or service (s) and institution (s) (s) to which the work must be attributed. No need to include the academic or professional position of the authors. An acknowledgment of any grant or financial aid, and the declaration of the existence of conflicts of interest of each of the authors.
Section shall contain the full name, e-mail (if available) and full postal address of author to whom correspondence is addressed, who will be responsible for the correctness of the tests.
2.3.2. Summary and keywords
The structured abstract should appear on the second page of the manuscript and have a maximum of 250 words in the case of the original 150 in the clinical notes.
Have the following headings: Objectives, noting the fundamental purpose of labor, material and methods, explaining the design of the study, criteria for evaluating diagnostic tests and the temporal direction (retrospective or prospective). Mentioning the procedure for selection of patients, inclusion criteria and / or exclusion, and the number of patients who begin and end the study. If experimental work, indicate the number and type of animals used, Results, which will contain the most relevant and significant results of the study and its statistical evaluation, and conclusions, which states that support them directly in the data, along with their clinical applicability. We will have to give equal emphasis to positive and negative findings with similar scientific interest.
Below the summary will include keywords, from 3 to 10 in total, with the aim of supplementing the information contained in the title and help identify the work in the bibliographic databases. For keywords you should use terms equivalent to those obtained from the list of descriptors in Health Science (Medical Subject Headings, MeSH) of Index Medicus (available at www.nlm.nih.gov/mesh/meshhome.html).
Important: You need not send the abstract and keywords in English. This will be done by the translator of the Journal.
2.3.3. Introduction
Must be clearly stated work objectives and summarize the rationale of it, without extensively reviewing the issue and eliminating historical memories. Quote only those references are strictly necessary.
2.3.4. Material and methods
This section must specify the place, time and study population. Authors should include information on how the design was made, how they were selected subjects, on all the technical, analytical results and other tests and measurements. All with enough detail so that other researchers can replicate the study without difficulty.
At the end of this section, indicate what was the type of statistical analysis used, indicating the confidence interval. Studies have appropriate experiments or control groups, otherwise, will explain the measures used to avoid bias and discuss its possible effect on the conclusions of the study. If this is an original methodology, will explain the reasons which have led to its use and describe their possible limitations.
They must show the names of patients or include any information that could lead to their identification. With respect to drugs, we will use the generic name of drugs used in the study by avoiding trade names, and detailing the maximum prescribed dose, route of administration and management time.
Also indicate the ethical standards followed by the researchers, both in studies in humans and animals. Studies in human beings must have the express approval of the Local Committee of Ethics and Clinical Trials. Authors should note that the procedures used in patients and controls were performed after obtaining informed consent.
2.3.5. Results
Results should be presented in a logical sequence and consistent in the text and tables and figures. The data can be displayed in tables or figures, but not simultaneously in both. The text should highlight the important observations, without repeating all the data presented in tables or figures. Do not mix the presentation of the results with your discussion.
2.3.6. Discussion
This is a discussion of the results obtained in this work and not a general review of the topic. Authors should emphasize new and important aspects that provide labor and proposed conclusions from them. Do not repeat in detail data shown in the results section. In the discussion, the authors should affect the concordance or discordance of their findings and their limitations, comparing them with other relevant studies identified from the respective references. In the end, conclusions must link with the purpose or purposes of the study, as collected in the introduction. Avoid making conclusions that are not supported by the findings, as well as support these findings in other work not yet completed. If necessary, authors may suggest new hypotheses, but they must be clearly identified as such. When appropriate, authors can submit their recommendations.
2.3.7. Bibliography
They include only those appointments that are considered important and have been read by the authors. All references must be cited in the text consecutively in the order of appearance, and identified by Arabic numerals call superscript. References cited only in tables or legends should be numbered according to the sequence established by the first identification in the text in tables or figures.
When presenting the first and last pages of an appointment must be shown on the final page only the digits that differ from the homepage (examples: 23-9, and 23-29, 247-51. And 247-251). At all times you must follow the rules of the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals," which can be obtained from the New England Journal of Medicine (N Engl J Med 1997; 336:309-15) and are also available at www.icmje.org/.
The abbreviations for journal titles are derived from the formats used by the National Library of Medicine USA, in the Index Medicus (available at www.ncbi.nlm.nih.gov/entrez/jrbrowser.cgi).
Avoid references style:''unpublished observations'',''personal communication''or similar. Manuscripts accepted and published at the time not to be cited quotations may be included as''in press''.
2.3.8. Tables
Be numbered with Arabic numerals in ascending order in the order of appearance in the text, and included in the manuscript at the end of it, after the bibliography. Be prepared space and a half, like the rest of the manuscript, and should not change the font. Be identified with corresponding numbers and a brief but sufficiently explanatory title at the top. The legend of the table must allow an understanding of its contents, without the reader having to go to the text for your understanding. Each column of the table must contain a short header. You must include the necessary explanatory notes to the table and use calls as a superscript lowercase letters in alphabetical order (a, b, c).
The tables should include statistical measures of variation such as standard deviation and standard error of the mean. Only used the decimal clinical significance, such as blood glucose levels must be reported as 89.7 89.67.
2.3.9. Figures
All graphics, photographs and illustrations are considered figures. The figures are identified with Arabic numbers that match their order of appearance in the text. The feet of the figures will be prepared and a half spaced on separate pages. Legends and figure legends must contain sufficient information to interpret the data presented without recourse to the text. For explanation caption calls will be used as a superscript lowercase letters, as previously indicated in the tables. In the photographs of histological preparations should include the type of stain and magnification. The minimum resolution of images should be 300 dpi (dots per inch).
3.1.Receipt of manuscripts
Once manuscripts are received (which will be confirmed by means of an acknowledgement from the publisher), it will be assigned a reference number and registered with the editor of the Review, the corresponding author being notified of the initiation of the review process.
3.2.First evaluation
The manuscript will initially be evaluated by a member of the editorial committee who will assess its appropriateness to the content of the Review, and will carry out a first evaluation of the author’s compliance with the rules of publication. In cases of significant non-compliance the manuscript will be returned to the authors before the review process continues, requesting that the errors found are corrected.
3.3.Peer review
In cases where the manuscript is appropriate for review, or once errors indicated earlier have been corrected, the Editorial Committee will request a review of the manuscript from two external anonymous reviewers, recognised specialists in the field which the work addresses. . The manuscripts will be submitted to the reviewers without including any data identifying the authors. Thus, the review will be double blind: neither the reviewers knowing the identity of the authors, nor the authors knowing which reviewers have evaluated the manuscript. The Review will guarantee strict compliance with this double anonymity.
3.4.Duration of the review process
The duration of the review process will depend on the time taken by the reviewers to send their reports. They will be requested to submit these reports within a maximum period of 3 weeks. Once the reports are received, the Editorial Committee will assess them and send them on to the authors, asking that they address the suggestions and submit the work afresh, with a report on a separate sheet detailing their compliance with these suggestions, within a maximum period of 15 days.
Once the manuscript with the corrections made is received it will be submitted again to the reviewers for them to report if the suggestions have been complied with or not. The reviewers will be asked to complete this final step within 72 hours.
3.5.Advance on-line
With the approval of the reviewers, the manuscript will be proofread by the editor before proceeding to layout by the publisher, with the galley-proof being sent to the corresponding author for their final approval prior to its publication as “advance on-line” on the Review’s web site. The time authors will be given for this final review will be limited to 48 hours.
Of the manuscripts published as “advance on-line”, the Editorial Committee will decide which will be published in the different numbers of the review, and when, as appropriate. The Review is responsible for the translation into English of all manuscripts.
The process of review and publication will generally be completed in 3 months, obviously depending on compliance with the timescales set out above on the part of both the reviewers and the authors.
4.1.Originales
Those are original clinical or experimental work of any kind related to bone mineral metabolism.
Should be structured in Introduction, Material and Methods, Results, Discussion and References. The maximum length is 16 pages and will be accepted up to 5 tables or figures. They should not exceed 40 references. Include a structured abstract of 250 words. This summary is organized into the following sections: Background, Objectives, and Methods, Results and Conclusions.
4.2. Clinical Notes
Description of one or more clinical cases involving exceptional observation of a significant contribution to knowledge of bone mineral metabolism. Must be accompanied by a summary and a brief introduction (maximum 150 words each) and prior to the description of the case. The maximum length of the text be 5 pages (1,750 words, 10,650 characters with spaces). Will be accepted up to two figures and two tables. It is advisable that the number of signatories not exceeding six and not include more than 20 references.
4.3. Letters to the Editor
In this section we publish those letters that refer to work previously published in the journal and those who provide opinions, comments or experiences that their characteristics can be summarized in a brief text. The maximum length is 60 lines and accepted a figure or table and ten references maximum. The number of signatures should not exceed four.
4.4. Other sections
The journal includes other sections (editorials, reviews and documents or special items), which will be commissioned by the Drafting Committee. The authors wish to collaborate spontaneously in any of these sections must consult the Director of the Magazine.
4.4.1. Reviews
Will be presented with an area of 12 pages (4,200 words, 25,560 characters with spaces) and a maximum of 60 appointments. A maximum of 4 figures and 5 tables that clearly must contribute to a better understanding of the text. The revisions will be accompanied by an abstract in Spanish and have a final section of conclusions about a folio in length.
4.4.2. Editorials
They should not exceed 4 pages (2,100 words, 12,780 characters with spaces), no tables or figures, and a maximum of 30 references.
4.4.3. Special documents
This section will be included in all documents and items that might make any scientific contribution to the field of bone mineral metabolism and possessing characteristics that do not allow their inclusion in any of the previous sections of the magazine. The Editorial Board will decide how to publish these documents and reserves the right to modify them to fit the format of the Journal.
5.1. Guarantees and responsibility of the author
When sending e-mail work, the author ensures that all material submitted to the Journal of Osteoporosis and Mineral Metabolism for publication is original, and that it has not been previously published or simultaneously submitted to any other Journal for publication.
The author also warrants that the work complies refers Data Protection Act and has obtained the prior written consent of patients or their relatives for publication.
5.2. Transfer of operating rights
The author assigns exclusively to the SEIOMM, with power to transfer to third parties, all exploitation rights arising from the manuscripts that are selected for publication in the Journal, and in particular reproduction, distribution and public communication in all its forms.
The author may not publish or broadcast the works that are selected for publication in Journal of Osteoporosis and Mineral Metabolism in whole or in part, nor authorize its publication to third parties, without the prior express permission, granted in writing, of the SEIOMM.
Posting Rules
Information for authors
1) General information. Editorial Policy
The Journal of Osteoporosis and Mineral Metabolism (Miner Metab Rev Osteoporos; www.revistadeosteoporosisymetabolismomineral.es) is the scientific journal of the Spanish Society for Bone and Mineral Metabolism (SEIOMM). It is published quarterly (4 issues per year: winter, spring, summer and fall) with a variable number of outstanding monographs. The third issue of the year, summer, is intended for publication of communications SEIOMM Annual Congress.The Journal of Osteoporosis and Mineral Metabolism publishes works in Spanish, which will be translated into English in its electronic format, and is offered freely and through its website. Access is complete all items in both languages, no grace period or seizure without registration. The paper version is published only in Spanish, and distributed by mail to SEIOMM partners and subscribers of the magazine.
The manuscripts will be considered by the Steering Committee of the Journal. All manuscripts will be evaluated by at least two referees, experts in this area, which made its assessment in a blinded fashion.
The Expert Committee is constituted by a group of collaborators specialized in different fields of bone and mineral metabolism that perform the evaluation of manuscripts at the request of the Steering Committee of the Journal. On the website of the Journal and in every issue of the Journal published the list of contributors who form the Committee of Experts. Also in the first issue of each year publish the names of reviewers who have actively collaborated with the magazine in the year ending.
The authors, if they wish, propose at least 3 potential external reviewers, of whom, besides the name, you must include your email address and why they believe they can objectively evaluate the article. They may also indicate those reviewers who do not wish to evaluate the manuscript, must also justify this fact, though its handling is strictly confidential by the team of the Journal.
The views and opinions expressed in articles published in the Journal of Osteoporosis and Mineral Metabolism is the author or authors and not necessarily of the Committee. Both the Steering Committee as SEIOMM disclaim any responsibility. Neither the Management Committee or the SEIOMM guarantee or support any product that is advertised in the magazine, nor guarantee claims made by the manufacturer of that product or service.
2) Preparation and submission of manuscripts
Manuscripts should be prepared following the recommendations of the International Committee of Medical Journal Editors, available at www.icmje.org and emailed to the address romm@ibanezyplaza.com.The Journal Editorial will acknowledge receipt immediately by e-mail also, and the editorial review process begins, which is usually completed in less than 3 months.
2. 1. Cover letter
All manuscripts should be accompanied necessarily a cover letter indicating: 1) the section of the journal in which you want to publish, 2) a brief explanation of what the original contribution and relevance of work in the field of metabolic bone disease, 3) a statement that the manuscript is original and has not been submitted simultaneously to another journal evaluation, and 4) have been observed these "instructions for authors."
2.2. Manuscripts
The full text of the manuscript, from the title page to references should be included in a file written in Word, in Arial size 12, 1.5 line spacing and justified to the left. Pages should be numbered consecutively in the upper right and you should leave a margin of 3 cm in the 4 edges of the page (which will be A4 size).
Only use common abbreviations in the field of medicine and avoid using abbreviations in the title and abstract work. The first occurrence of an abbreviation should be preceded by the full term to which it relates, except in the case of common measurement units, which are expressed in SI units.
The work shall include the information requested below, ordering sections as follows: title page and authors, summary page and keywords, text (introduction, material and methods, results, discussion and references), tables and figures . If necessary, you may include tables and figures in another attachment, with their respective titles and numbering.
2.3. Sections of the manuscript
2.3.1. Title page and authors:
Shall include the following information:
- The title, which should adequately describe the content of work. It should be brief, clear and informative. Include the full name and surname of the authors, or both names separate or by script, depending on how the authors prefer to appear in publications.
- The name (s) department (s) or service (s) and institution (s) (s) to which the work must be attributed. No need to include the academic or professional position of the authors. An acknowledgment of any grant or financial aid, and the declaration of the existence of conflicts of interest of each of the authors.
Section shall contain the full name, e-mail (if available) and full postal address of author to whom correspondence is addressed, who will be responsible for the correctness of the tests.
2.3.2. Summary and keywords
The structured abstract should appear on the second page of the manuscript and have a maximum of 250 words in the case of the original 150 in the clinical notes.
Have the following headings: Objectives, noting the fundamental purpose of labor, material and methods, explaining the design of the study, criteria for evaluating diagnostic tests and the temporal direction (retrospective or prospective). Mentioning the procedure for selection of patients, inclusion criteria and / or exclusion, and the number of patients who begin and end the study. If experimental work, indicate the number and type of animals used, Results, which will contain the most relevant and significant results of the study and its statistical evaluation, and conclusions, which states that support them directly in the data, along with their clinical applicability. We will have to give equal emphasis to positive and negative findings with similar scientific interest.
Below the summary will include keywords, from 3 to 10 in total, with the aim of supplementing the information contained in the title and help identify the work in the bibliographic databases. For keywords you should use terms equivalent to those obtained from the list of descriptors in Health Science (Medical Subject Headings, MeSH) of Index Medicus (available at www.nlm.nih.gov/mesh/meshhome.html).
Important: You need not send the abstract and keywords in English. This will be done by the translator of the Journal.
2.3.3. Introduction
Must be clearly stated work objectives and summarize the rationale of it, without extensively reviewing the issue and eliminating historical memories. Quote only those references are strictly necessary.
2.3.4. Material and methods
This section must specify the place, time and study population. Authors should include information on how the design was made, how they were selected subjects, on all the technical, analytical results and other tests and measurements. All with enough detail so that other researchers can replicate the study without difficulty.
At the end of this section, indicate what was the type of statistical analysis used, indicating the confidence interval. Studies have appropriate experiments or control groups, otherwise, will explain the measures used to avoid bias and discuss its possible effect on the conclusions of the study. If this is an original methodology, will explain the reasons which have led to its use and describe their possible limitations.
They must show the names of patients or include any information that could lead to their identification. With respect to drugs, we will use the generic name of drugs used in the study by avoiding trade names, and detailing the maximum prescribed dose, route of administration and management time.
Also indicate the ethical standards followed by the researchers, both in studies in humans and animals. Studies in human beings must have the express approval of the Local Committee of Ethics and Clinical Trials. Authors should note that the procedures used in patients and controls were performed after obtaining informed consent.
2.3.5. Results
Results should be presented in a logical sequence and consistent in the text and tables and figures. The data can be displayed in tables or figures, but not simultaneously in both. The text should highlight the important observations, without repeating all the data presented in tables or figures. Do not mix the presentation of the results with your discussion.
2.3.6. Discussion
This is a discussion of the results obtained in this work and not a general review of the topic. Authors should emphasize new and important aspects that provide labor and proposed conclusions from them. Do not repeat in detail data shown in the results section. In the discussion, the authors should affect the concordance or discordance of their findings and their limitations, comparing them with other relevant studies identified from the respective references. In the end, conclusions must link with the purpose or purposes of the study, as collected in the introduction. Avoid making conclusions that are not supported by the findings, as well as support these findings in other work not yet completed. If necessary, authors may suggest new hypotheses, but they must be clearly identified as such. When appropriate, authors can submit their recommendations.
2.3.7. Bibliography
They include only those appointments that are considered important and have been read by the authors. All references must be cited in the text consecutively in the order of appearance, and identified by Arabic numerals call superscript. References cited only in tables or legends should be numbered according to the sequence established by the first identification in the text in tables or figures.
When presenting the first and last pages of an appointment must be shown on the final page only the digits that differ from the homepage (examples: 23-9, and 23-29, 247-51. And 247-251). At all times you must follow the rules of the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals," which can be obtained from the New England Journal of Medicine (N Engl J Med 1997; 336:309-15) and are also available at www.icmje.org/.
The abbreviations for journal titles are derived from the formats used by the National Library of Medicine USA, in the Index Medicus (available at www.ncbi.nlm.nih.gov/entrez/jrbrowser.cgi).
Avoid references style:''unpublished observations'',''personal communication''or similar. Manuscripts accepted and published at the time not to be cited quotations may be included as''in press''.
2.3.8. Tables
Be numbered with Arabic numerals in ascending order in the order of appearance in the text, and included in the manuscript at the end of it, after the bibliography. Be prepared space and a half, like the rest of the manuscript, and should not change the font. Be identified with corresponding numbers and a brief but sufficiently explanatory title at the top. The legend of the table must allow an understanding of its contents, without the reader having to go to the text for your understanding. Each column of the table must contain a short header. You must include the necessary explanatory notes to the table and use calls as a superscript lowercase letters in alphabetical order (a, b, c).
The tables should include statistical measures of variation such as standard deviation and standard error of the mean. Only used the decimal clinical significance, such as blood glucose levels must be reported as 89.7 89.67.
2.3.9. Figures
All graphics, photographs and illustrations are considered figures. The figures are identified with Arabic numbers that match their order of appearance in the text. The feet of the figures will be prepared and a half spaced on separate pages. Legends and figure legends must contain sufficient information to interpret the data presented without recourse to the text. For explanation caption calls will be used as a superscript lowercase letters, as previously indicated in the tables. In the photographs of histological preparations should include the type of stain and magnification. The minimum resolution of images should be 300 dpi (dots per inch).
3. Process for review of manuscripts
3.1.Receipt of manuscripts
Once manuscripts are received (which will be confirmed by means of an acknowledgement from the publisher), it will be assigned a reference number and registered with the editor of the Review, the corresponding author being notified of the initiation of the review process.
3.2.First evaluation
The manuscript will initially be evaluated by a member of the editorial committee who will assess its appropriateness to the content of the Review, and will carry out a first evaluation of the author’s compliance with the rules of publication. In cases of significant non-compliance the manuscript will be returned to the authors before the review process continues, requesting that the errors found are corrected.
3.3.Peer review
In cases where the manuscript is appropriate for review, or once errors indicated earlier have been corrected, the Editorial Committee will request a review of the manuscript from two external anonymous reviewers, recognised specialists in the field which the work addresses. . The manuscripts will be submitted to the reviewers without including any data identifying the authors. Thus, the review will be double blind: neither the reviewers knowing the identity of the authors, nor the authors knowing which reviewers have evaluated the manuscript. The Review will guarantee strict compliance with this double anonymity.
3.4.Duration of the review process
The duration of the review process will depend on the time taken by the reviewers to send their reports. They will be requested to submit these reports within a maximum period of 3 weeks. Once the reports are received, the Editorial Committee will assess them and send them on to the authors, asking that they address the suggestions and submit the work afresh, with a report on a separate sheet detailing their compliance with these suggestions, within a maximum period of 15 days.
Once the manuscript with the corrections made is received it will be submitted again to the reviewers for them to report if the suggestions have been complied with or not. The reviewers will be asked to complete this final step within 72 hours.
3.5.Advance on-line
With the approval of the reviewers, the manuscript will be proofread by the editor before proceeding to layout by the publisher, with the galley-proof being sent to the corresponding author for their final approval prior to its publication as “advance on-line” on the Review’s web site. The time authors will be given for this final review will be limited to 48 hours.
Of the manuscripts published as “advance on-line”, the Editorial Committee will decide which will be published in the different numbers of the review, and when, as appropriate. The Review is responsible for the translation into English of all manuscripts.
The process of review and publication will generally be completed in 3 months, obviously depending on compliance with the timescales set out above on the part of both the reviewers and the authors.
4. Specific rules for each section
4.1.Originales
Those are original clinical or experimental work of any kind related to bone mineral metabolism.
Should be structured in Introduction, Material and Methods, Results, Discussion and References. The maximum length is 16 pages and will be accepted up to 5 tables or figures. They should not exceed 40 references. Include a structured abstract of 250 words. This summary is organized into the following sections: Background, Objectives, and Methods, Results and Conclusions.
4.2. Clinical Notes
Description of one or more clinical cases involving exceptional observation of a significant contribution to knowledge of bone mineral metabolism. Must be accompanied by a summary and a brief introduction (maximum 150 words each) and prior to the description of the case. The maximum length of the text be 5 pages (1,750 words, 10,650 characters with spaces). Will be accepted up to two figures and two tables. It is advisable that the number of signatories not exceeding six and not include more than 20 references.
4.3. Letters to the Editor
In this section we publish those letters that refer to work previously published in the journal and those who provide opinions, comments or experiences that their characteristics can be summarized in a brief text. The maximum length is 60 lines and accepted a figure or table and ten references maximum. The number of signatures should not exceed four.
4.4. Other sections
The journal includes other sections (editorials, reviews and documents or special items), which will be commissioned by the Drafting Committee. The authors wish to collaborate spontaneously in any of these sections must consult the Director of the Magazine.
4.4.1. Reviews
Will be presented with an area of 12 pages (4,200 words, 25,560 characters with spaces) and a maximum of 60 appointments. A maximum of 4 figures and 5 tables that clearly must contribute to a better understanding of the text. The revisions will be accompanied by an abstract in Spanish and have a final section of conclusions about a folio in length.
4.4.2. Editorials
They should not exceed 4 pages (2,100 words, 12,780 characters with spaces), no tables or figures, and a maximum of 30 references.
4.4.3. Special documents
This section will be included in all documents and items that might make any scientific contribution to the field of bone mineral metabolism and possessing characteristics that do not allow their inclusion in any of the previous sections of the magazine. The Editorial Board will decide how to publish these documents and reserves the right to modify them to fit the format of the Journal.
5. Transfer of copyright
5.1. Guarantees and responsibility of the author
When sending e-mail work, the author ensures that all material submitted to the Journal of Osteoporosis and Mineral Metabolism for publication is original, and that it has not been previously published or simultaneously submitted to any other Journal for publication.
The author also warrants that the work complies refers Data Protection Act and has obtained the prior written consent of patients or their relatives for publication.
5.2. Transfer of operating rights
The author assigns exclusively to the SEIOMM, with power to transfer to third parties, all exploitation rights arising from the manuscripts that are selected for publication in the Journal, and in particular reproduction, distribution and public communication in all its forms.
The author may not publish or broadcast the works that are selected for publication in Journal of Osteoporosis and Mineral Metabolism in whole or in part, nor authorize its publication to third parties, without the prior express permission, granted in writing, of the SEIOMM.
Databases
The Journal is included in the following databases:
